In contrast to the results obtained with CD154 + IL-4, pooled analysis of eight CLL samples stimulated with CD154 + IL-21 failed to show any significant changes in the percentage of divided cells as a result of AKT inhibition with AZD5363 (P > 0.05). Here, IL4 is linked to B-cell chronic lymphocytic leukemia.